Work

Abstract 5599: A novel orally available anti-cancer drug candidate, SB17170, represses myeloid-derived suppressor cells by targeting HMGB1

Year: 2022
Type: conference-abstract
Language: English
Subfield: Immunology
Open Access status: closed
OpenAlex ID: W4282966947
Cites:
Cited by: 7
Related to: 10